Retrospective evaluation of operated stage I breast cancer patients
As there is no national screening programme in our country, information about stage I breast carcinoma is limited. In this study, 131 stage I breast cancer patients followed between April 1989 and March 2001 at our department, were retrospectively evaluated. Median age was 49 (range: 26-77). Painles...
Gespeichert in:
| Veröffentlicht in: | Turkish journal of cancer 2003-01, Vol.33 (1), p.40-50 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 50 |
|---|---|
| container_issue | 1 |
| container_start_page | 40 |
| container_title | Turkish journal of cancer |
| container_volume | 33 |
| creator | Berna Öksüzoglu Nilüfer Güler Esmen Baltali Karaoglu, Aziz |
| description | As there is no national screening programme in our country, information about stage I breast carcinoma is limited. In this study, 131 stage I breast cancer patients followed between April 1989 and March 2001 at our department, were retrospectively evaluated. Median age was 49 (range: 26-77). Painless breast mass was the most common symptom (75%). Tumor size was larger than 1 cm in 66% of the patients. Seven percent of the patients had no adjuvant therapy, 43% had adjuvant tamoxifen and 50% had adjuvant chemotherapy ± tamoxifen. CMF combination (± tamoxifen) was the most common (71%) adjuvant chemotherapy regimen. Median follow-up period was 43 (range: 5+-148+) months. During the follow-up period, 1 patient had local recurrence and distant metastases, 3 had distant metastasis, and 5 patients (3.8%) had metachronous breast carcinoma. Two patients died with distant metastasis. Median disease free survival and median overall survival were not reached. Five-year disease free survival was 97% and, 5-year overall su rvival was 98.5%. Follow-up period was short and long-term follow-up is necessary for better analysis. |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_ulakb</sourceid><recordid>TN_cdi_ulakbim_primary_23207</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>817449681</sourcerecordid><originalsourceid>FETCH-LOGICAL-p1167-b3a5fef8adac9d44fb205bdbb0d711fbbdda0a12d58e8585a91af49f6099876b3</originalsourceid><addsrcrecordid>eNotj81KxDAYRbNQcBx9AxfBfSE_TdMspfgzMDAgui5fmi_SsdPEJB3w7S2Mq7s4l8O9V2TDGTeV5EzekNucj4wJWSu1Id07lhRyxKGMZ6R4hmmBMoaZBk9DxAQFHc0FvpDuqE0IudAB5gETjWsR55LvyLWHKeP9f27J58vzR_dW7Q-vu-5pX0XOG11ZCcqjb8HBYFxdeyuYss5a5jTn3lrngAEXTrXYqlaB4eBr4xtmTKsbK7fk4eJdJvi246mPaTxB-u2FFEyv-PGCYwo_C-bSH8OS5nVRL7jWUjTr6T-jVFA0</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>217732602</pqid></control><display><type>article</type><title>Retrospective evaluation of operated stage I breast cancer patients</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Berna Öksüzoglu ; Nilüfer Güler ; Esmen Baltali ; Karaoglu, Aziz</creator><creatorcontrib>Berna Öksüzoglu ; Nilüfer Güler ; Esmen Baltali ; Karaoglu, Aziz</creatorcontrib><description>As there is no national screening programme in our country, information about stage I breast carcinoma is limited. In this study, 131 stage I breast cancer patients followed between April 1989 and March 2001 at our department, were retrospectively evaluated. Median age was 49 (range: 26-77). Painless breast mass was the most common symptom (75%). Tumor size was larger than 1 cm in 66% of the patients. Seven percent of the patients had no adjuvant therapy, 43% had adjuvant tamoxifen and 50% had adjuvant chemotherapy ± tamoxifen. CMF combination (± tamoxifen) was the most common (71%) adjuvant chemotherapy regimen. Median follow-up period was 43 (range: 5+-148+) months. During the follow-up period, 1 patient had local recurrence and distant metastases, 3 had distant metastasis, and 5 patients (3.8%) had metachronous breast carcinoma. Two patients died with distant metastasis. Median disease free survival and median overall survival were not reached. Five-year disease free survival was 97% and, 5-year overall su rvival was 98.5%. Follow-up period was short and long-term follow-up is necessary for better analysis.</description><identifier>ISSN: 1019-3103</identifier><language>eng</language><publisher>Ankara: Turkish Association for Cancer Research and Control</publisher><subject>Breast Neoplasms ; Chemotherapy, Adjuvant ; Combined Modality Therapy ; Geriyedönük çalışma ; Kemoterapi, adjuvan ; Kombine tedavi uygulaması ; Meme neoplazmları ; Neoplasm Staging ; Neoplasms ; Neoplazm evrelendirilmesi ; Neoplazmlar ; Prognosis ; Retrospective Studies ; Sağkalım ; Seyir ; Survival ; Terapötik ; Therapeutics</subject><ispartof>Turkish journal of cancer, 2003-01, Vol.33 (1), p.40-50</ispartof><rights>Copyright Turkish Association for Cancer Research and Control Jan-Mar 2003</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,777,781,882,4010</link.rule.ids></links><search><creatorcontrib>Berna Öksüzoglu</creatorcontrib><creatorcontrib>Nilüfer Güler</creatorcontrib><creatorcontrib>Esmen Baltali</creatorcontrib><creatorcontrib>Karaoglu, Aziz</creatorcontrib><title>Retrospective evaluation of operated stage I breast cancer patients</title><title>Turkish journal of cancer</title><description>As there is no national screening programme in our country, information about stage I breast carcinoma is limited. In this study, 131 stage I breast cancer patients followed between April 1989 and March 2001 at our department, were retrospectively evaluated. Median age was 49 (range: 26-77). Painless breast mass was the most common symptom (75%). Tumor size was larger than 1 cm in 66% of the patients. Seven percent of the patients had no adjuvant therapy, 43% had adjuvant tamoxifen and 50% had adjuvant chemotherapy ± tamoxifen. CMF combination (± tamoxifen) was the most common (71%) adjuvant chemotherapy regimen. Median follow-up period was 43 (range: 5+-148+) months. During the follow-up period, 1 patient had local recurrence and distant metastases, 3 had distant metastasis, and 5 patients (3.8%) had metachronous breast carcinoma. Two patients died with distant metastasis. Median disease free survival and median overall survival were not reached. Five-year disease free survival was 97% and, 5-year overall su rvival was 98.5%. Follow-up period was short and long-term follow-up is necessary for better analysis.</description><subject>Breast Neoplasms</subject><subject>Chemotherapy, Adjuvant</subject><subject>Combined Modality Therapy</subject><subject>Geriyedönük çalışma</subject><subject>Kemoterapi, adjuvan</subject><subject>Kombine tedavi uygulaması</subject><subject>Meme neoplazmları</subject><subject>Neoplasm Staging</subject><subject>Neoplasms</subject><subject>Neoplazm evrelendirilmesi</subject><subject>Neoplazmlar</subject><subject>Prognosis</subject><subject>Retrospective Studies</subject><subject>Sağkalım</subject><subject>Seyir</subject><subject>Survival</subject><subject>Terapötik</subject><subject>Therapeutics</subject><issn>1019-3103</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNotj81KxDAYRbNQcBx9AxfBfSE_TdMspfgzMDAgui5fmi_SsdPEJB3w7S2Mq7s4l8O9V2TDGTeV5EzekNucj4wJWSu1Id07lhRyxKGMZ6R4hmmBMoaZBk9DxAQFHc0FvpDuqE0IudAB5gETjWsR55LvyLWHKeP9f27J58vzR_dW7Q-vu-5pX0XOG11ZCcqjb8HBYFxdeyuYss5a5jTn3lrngAEXTrXYqlaB4eBr4xtmTKsbK7fk4eJdJvi246mPaTxB-u2FFEyv-PGCYwo_C-bSH8OS5nVRL7jWUjTr6T-jVFA0</recordid><startdate>20030101</startdate><enddate>20030101</enddate><creator>Berna Öksüzoglu</creator><creator>Nilüfer Güler</creator><creator>Esmen Baltali</creator><creator>Karaoglu, Aziz</creator><general>Turkish Association for Cancer Research and Control</general><general>Hacettepe Üniversitesi Onkoloji Enstitüsü</general><scope>3V.</scope><scope>4T-</scope><scope>7X7</scope><scope>7XB</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PADUT</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>GIY</scope><scope>GIZ</scope><scope>GJA</scope><scope>GJB</scope></search><sort><creationdate>20030101</creationdate><title>Retrospective evaluation of operated stage I breast cancer patients</title><author>Berna Öksüzoglu ; Nilüfer Güler ; Esmen Baltali ; Karaoglu, Aziz</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p1167-b3a5fef8adac9d44fb205bdbb0d711fbbdda0a12d58e8585a91af49f6099876b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Breast Neoplasms</topic><topic>Chemotherapy, Adjuvant</topic><topic>Combined Modality Therapy</topic><topic>Geriyedönük çalışma</topic><topic>Kemoterapi, adjuvan</topic><topic>Kombine tedavi uygulaması</topic><topic>Meme neoplazmları</topic><topic>Neoplasm Staging</topic><topic>Neoplasms</topic><topic>Neoplazm evrelendirilmesi</topic><topic>Neoplazmlar</topic><topic>Prognosis</topic><topic>Retrospective Studies</topic><topic>Sağkalım</topic><topic>Seyir</topic><topic>Survival</topic><topic>Terapötik</topic><topic>Therapeutics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Berna Öksüzoglu</creatorcontrib><creatorcontrib>Nilüfer Güler</creatorcontrib><creatorcontrib>Esmen Baltali</creatorcontrib><creatorcontrib>Karaoglu, Aziz</creatorcontrib><collection>ProQuest Central (Corporate)</collection><collection>Docstoc</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Research Library China</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>ULAKBIM - Mühendislik ve Temel Bilimler Veri Tabani</collection><collection>ULAKBIM - Yaşam Bilimleri Veri Tabani</collection><collection>ULAKBIM - Turk Sosyal Bilimler Veri Tabani</collection><collection>ULAKBIM - Türk Tıp Veri Tabani</collection><jtitle>Turkish journal of cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Berna Öksüzoglu</au><au>Nilüfer Güler</au><au>Esmen Baltali</au><au>Karaoglu, Aziz</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Retrospective evaluation of operated stage I breast cancer patients</atitle><jtitle>Turkish journal of cancer</jtitle><date>2003-01-01</date><risdate>2003</risdate><volume>33</volume><issue>1</issue><spage>40</spage><epage>50</epage><pages>40-50</pages><issn>1019-3103</issn><abstract>As there is no national screening programme in our country, information about stage I breast carcinoma is limited. In this study, 131 stage I breast cancer patients followed between April 1989 and March 2001 at our department, were retrospectively evaluated. Median age was 49 (range: 26-77). Painless breast mass was the most common symptom (75%). Tumor size was larger than 1 cm in 66% of the patients. Seven percent of the patients had no adjuvant therapy, 43% had adjuvant tamoxifen and 50% had adjuvant chemotherapy ± tamoxifen. CMF combination (± tamoxifen) was the most common (71%) adjuvant chemotherapy regimen. Median follow-up period was 43 (range: 5+-148+) months. During the follow-up period, 1 patient had local recurrence and distant metastases, 3 had distant metastasis, and 5 patients (3.8%) had metachronous breast carcinoma. Two patients died with distant metastasis. Median disease free survival and median overall survival were not reached. Five-year disease free survival was 97% and, 5-year overall su rvival was 98.5%. Follow-up period was short and long-term follow-up is necessary for better analysis.</abstract><cop>Ankara</cop><pub>Turkish Association for Cancer Research and Control</pub><tpages>11</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1019-3103 |
| ispartof | Turkish journal of cancer, 2003-01, Vol.33 (1), p.40-50 |
| issn | 1019-3103 |
| language | eng |
| recordid | cdi_ulakbim_primary_23207 |
| source | Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
| subjects | Breast Neoplasms Chemotherapy, Adjuvant Combined Modality Therapy Geriyedönük çalışma Kemoterapi, adjuvan Kombine tedavi uygulaması Meme neoplazmları Neoplasm Staging Neoplasms Neoplazm evrelendirilmesi Neoplazmlar Prognosis Retrospective Studies Sağkalım Seyir Survival Terapötik Therapeutics |
| title | Retrospective evaluation of operated stage I breast cancer patients |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T05%3A58%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_ulakb&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Retrospective%20evaluation%20of%20operated%20stage%20I%20breast%20cancer%20patients&rft.jtitle=Turkish%20journal%20of%20cancer&rft.au=Berna%20%C3%96ks%C3%BCzoglu&rft.date=2003-01-01&rft.volume=33&rft.issue=1&rft.spage=40&rft.epage=50&rft.pages=40-50&rft.issn=1019-3103&rft_id=info:doi/&rft_dat=%3Cproquest_ulakb%3E817449681%3C/proquest_ulakb%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=217732602&rft_id=info:pmid/&rfr_iscdi=true |